cm 7116 has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies
norflutoprazepam: structure
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quazepam and flurazepam share pharmacokinetic properties that result in prevention of early-morning insomnia, daytime rebound anxiety, and withdrawal rebound insomnia." | 2.38 | Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics. ( Battista, D; Hilbert, JM, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hilbert, JM | 1 |
| Battista, D | 1 |
1 review available for cm 7116 and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Cricetinae; Flurazepam; Humans; Hy | 1991 |